| Company/Division name | Eurofins Lancaster Laboratories |
| Parent company | Eurofins BioPharma Product Testing |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 250 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2029 |
| Capital investment ($): | 147.5 |
| Country(ies) from which reshored: | Luxembourg |
| City reshored to: | Lancaster County |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | life sciences |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Proximity to customers/market, Skilled workforce availability/training, grants |
| Government Incentive dollar amount: | 2,175,000 |
